Skip to main
CAH

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health (CAH) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 58%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

Cardinal Health is financially stable and has a diversified portfolio with a strong presence not only in the US, but also in Canada and Europe. With their increased focus on higher-growth segments and opportunities for expansion, the company is poised for future success and continued growth. Furthermore, as supply chains and healthcare delivery continue to evolve, Cardinal Health's distribution capabilities and partnerships with key stakeholders put them in a favorable position for sustainability and profitability.

Bears say

Cardinal Health is facing potential challenges in the form of changes in tax rates, potential competition, and overall uncertainty, but analysts predict that growth from new customers and expansion into specialty services will outpace long-term targets. Additionally, the company's recent acquisitions in the specialty space and partnership with CVS in the generic market may help close the performance gap with competitors. However, external factors such as changes in drug pricing and global disruptions may affect profitability and cash flow, but the company has implemented measures to minimize these risks and is expected to continue seeing revenue growth in the future.

Cardinal Health (CAH) has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 58% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cardinal Health (CAH) Forecast

Analysts have given Cardinal Health (CAH) a Buy based on their latest research and market trends.

According to 12 analysts, Cardinal Health (CAH) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $235.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $235.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cardinal Health (CAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.